Xuequn Luo

Co-expression of a PD-L1-specific chimeric switch receptor augments the efficacy and persistence of CAR T cells via the CD70-CD27 axis

J. Thiery, Suna Wang, Zhenfeng Zhang, 2022, Nature Communications.

Disruption of CISH promotes the antitumor activity of human T cells and decreases PD-1 expression levels

L. Qin, Zhaoyang Tang, Peng Li, 2022, Molecular therapy oncolytics.

MiR-99a may serve as a potential oncogene in pediatric myeloid leukemia

Hua Zhang, Jun Wu, Zhi-yong Ke, 2013, Cancer Cell International.

Performance of PRISM III, PELOD-2, and P-MODS Scores in Two Pediatric Intensive Care Units in China

Wen Tang, Yuhui Wu, Lingling Xu, 2021, Frontiers in Pediatrics.

The onco-embryonic antigen ROR1 is a target of chimeric antigen T cells for colorectal cancer.

Peng Li, L. Qin, Zhaoyang Tang, 2023, International immunopharmacology.

CD318 is a target of chimeric antigen receptor T cells for the treatment of colorectal cancer

Ming Li, L. Qin, Zhaoyang Tang, 2022, Clinical and Experimental Medicine.